Skip to main content

Pediatric type 2 diabetes

ADA 2019

Today2 trial

Expert opinion

Exposure to diabetes technologies: Where now for adult services?

What does the proliferation of diabetes self-management and monitoring technologies in pediatric care mean for the future of adult services? Katharine Barnard looks at the situation in England. 

Get more on: Devices and technology | Pediatric diabetes

medwireNews top story

Ellipse trial: Liraglutide expands treatment options for pediatric type 2 diabetes

The Ellipse investigators report improved glycemic control at the price of early and mostly mild gastrointestinal events in children and adolescents with type 2 diabetes.

Interactive patient case study

Hypoglycemia and technology

This 15-minute case presents the identification of problematic hypoglycemia and the appropriate use and monitoring of different technologies in the context of reducing the occurrence and risk of hypoglycemia.

Get more on: Hypoglycemia | Devices and technology | Pediatric diabetes

medwireNews editor's pick

Ethnicity influences reversibility of dysglycemia in obese children

Impaired glucose tolerance in obese youths frequently reverts to normal, although the chances of this happening are strongly influenced by ethnicity, researchers report in The Lancet Child & Adolescent Health.

medwireNews@ADA2018

RISE: Early insulin does not slow beta cell decline in youth with type 2 diabetes

The RISE trial investigators have found that increased insulin resistance and hyperresponsive beta cells may explain the rapid progression of type 2 diabetes in children.

medwireNews editor's pick

Insulin, metformin remain most used treatments for type 2 diabetes in youths

The majority of adolescents and young adults with type 2 diabetes are still being treated with metformin and/or insulin, despite a growing number of medications being available for adults, US study data show.

Journal article

Glycemic impact of non-nutritive sweeteners: A systematic review and meta-analysis of randomized controlled trials

A systematic review and meta-analysis of randomized controlled trials was conducted to quantitatively synthesize existing scientific evidence on the glycemic impact of non-nutritive sweeteners [read more].
Nichol AD, Holle MJ, An R. Eur J Clin Nutr 2018. doi: 10.1038/s41430-018-0170-6

Get more on: Type 2 diabetes | Glycemic control | Diet and nutritional management

medwireNews editor's pick

Weight loss before puberty may mitigate excess diabetes risk associated with childhood overweight

Children who are overweight only have an increased risk for type 2 diabetes in adulthood if they remain overweight beyond the age of 13 years, according to the results of a large Danish study.

View from the clinic

Managing patient expectations for glucose management via a device

As the utility and availability of devices surges, so too do patient expectations. Advisory Board member Katharine Barnard provides key consultation questions to help determine your patients’ greatest needs and obstacles [read more].

Get more on: Devices and technology | Psychosocial care | Type 1 diabetes | Type 2 diabetes

medwireNews

02-03-2023 | Empagliflozin | News

DINAMO: Empagliflozin shows promise for young people with type 2 diabetes

Empagliflozin, but not linagliptin, provides “clinically relevant” improvements in glycemic control versus placebo in children and adolescents with type 2 diabetes, report the DINAMO investigators.

12-19-2022 | Early onset | News

Global type 2 diabetes burden increasing in adolescents and young adults

The incidence and burden of type 2 diabetes in young people aged 15–39 years are increasing worldwide, show data from the Global Burden of Disease Study.

11-22-2022 | Dulaglutide | News

FDA clears dulaglutide for adolescents

Click through to read more on this announcement

Themed collections

Fotolia_71753454_Subscription_Yearly_XXL

06-07-2017 | Psychosocial care | Themed collection | Collection

Psychosocial care in diabetes

This content collection summarizes recent publications dealing with various aspects of psychosocial care in patients with type 1 and type 2 diabetes.

This collection has been developed on behalf of Diabetes UK

Journal articles and book chapters

08-29-2018 | Risk factors | Review | Article

Early-life exposures and risk of diabetes mellitus and obesity

Gingras V, Hivert MF, Oken E. Curr Diab Rep 2018; 18: 89. doi: 10.1007/s11892-018-1050-0

08-28-2018 | Diet | Review | Article

Dietary interventions and type 2 diabetes in youth: A fresh look at the evidence

Perkison WB, Adekanye JA, de Oliveira Otto MC. Curr Nutr Rep 2018. doi: 10.1007/s13668-018-0241-2

07-14-2018 | Pediatrics | Review | Article

Disparities in care delivery and outcomes in young adults with diabetes

Agarwal S, Hilliard M, Butler A. Curr Diab Rep 2018; 18: 65. doi: 10.1007/s11892-018-1037-x

06-27-2018 | Metformin | Article

Metformin monotherapy in children and adolescents with type 2 diabetes mellitus in Japan

Matsuura N et al. Diabetol Int 2018. doi: 10.1007/s13340-018-0361-3

Guidelines

Guidelines

A convenient single access point, providing diabetes professionals with links to a comprehensive set of clinical practice guidelines from a wide range of relevant organizations.

Downloadable slides

Slides

Downloadable PowerPoint slide sets containing a variety of high-quality images and illustrations from Springer Nature’s library of published figures.

In practice

Practice tips

Practical information, guidance, and helpful resources for diabetes healthcare providers. Comprised of practical approaches, case studies, and more.

Themed collections

Themed collections

Compendia of selected, recently published, free full-text journal and book content from Springer Nature and other publishers on a particular topic within diabetes management, as recommended by our Editorial Board.

Independent Medical Education

Independent Medical Education

Educational programs building upon the most current research and professional practice recommendations, with the aim of enabling more efficient diagnosis, optimizing treatment, and improving patient outcomes.